{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-21-000699","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2021-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.261146+00:00","generated_at":"2026-06-29T20:21:47.488507+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lifeloc reports Q2 2021 net loss of $110K on $1.73M revenue, up 31% YoY","bullets":["Q2 revenue $1.73M, net loss $110K ($0.04 diluted) vs. $1.32M revenue and $350K loss in Q2 2020.","Six-month 2021 revenue $3.54M, net profit $294K ($0.12 diluted) includes $465K PPP loan forgiveness.","Received second PPP loan of $471K in Q1 2021; plans to apply for forgiveness in Q3 2021.","New L-series LX9 and LT7 devices gaining traction; R.A.D.A.R. 200 in field testing with release planned this year.","SpinDx marijuana breathalyzer development prioritized over short-term profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-21-000699","json":"https://secwatch.observer/filing/0001079973-21-000699.json","markdown":"https://secwatch.observer/filing/0001079973-21-000699.md","text":"https://secwatch.observer/filing/0001079973-21-000699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997321000699/0001079973-21-000699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997321000699/lclc_8k-q2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T20:21:47.488507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}